Expertise in
2
conditions

Amelie Deleporte

Brussels, BRU, BE 
Expertise in
2
conditions
Brussels, BRU, BE 

Overview

Amelie Deleporte practices practicing medicine in Brussels, Belgium.

Ms. Deleporte is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Colorectal Cancer, Febrile Neutropenia, Agranulocytosis, and Esophageal Cancer.

She is actively involved in clinical research, co-authoring 41 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Brussels, BRU, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Placebo-Controlled, Double-Blind Phase 3 Study to Evaluate the Efficacy and Safety of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First-Line Treatment in Patients With Unresectable, Locally Advanced Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
A Randomized, Placebo-Controlled, Double-Blind Phase 3 Study to Evaluate the Efficacy and Safety of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First-Line Treatment in Patients With Unresectable, Locally Advanced Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
Enrollment Status: Completed
Publish Date: July 29, 2025
Intervention Type: Drug, Biological
Study Drugs: Cisplatin, Capecitabine, Paclitaxel, Fluorouracil (5-FU), Oxaliplatin, Tislelizumab
Study Phase: Phase 3
Assessment of Metabolic and Pathological Response to Treatment With RCT and ImT Before Surgery in Locally Advanced Esophageal and Gastro-esophageal Junction Cancer: ARTemIS-Eso, a Three-level, Open-label, Phase I-II Study
Assessment of Metabolic and Pathological Response to Treatment With RCT and ImT Before Surgery in Locally Advanced Esophageal and Gastro-esophageal Junction Cancer: ARTemIS-Eso, a Three-level, Open-label, Phase I-II Study
Enrollment Status: Withdrawn
Publish Date: December 19, 2017
Intervention Type: Drug, Radiation, Other, Procedure
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

41 Total Publications

Mismatch repair deficiency or microsatellite instability in locally advanced rectal cancer patients treated with total neoadjuvant therapy.
Mismatch repair deficiency or microsatellite instability in locally advanced rectal cancer patients treated with total neoadjuvant therapy.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 07, 2026

Frequently Asked Questions about Amelie Deleporte

Is Amelie Deleporte a top-rated expert for Colorectal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Amelie Deleporte is classified as an Advanced expert for Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Amelie Deleporte participate in research or clinical trials?

Yes. Amelie Deleporte has published 41 articles and abstracts on conditions like Colorectal Cancer. You can view a list of Amelie Deleporte's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Deleporte's expertise for a condition
ConditionClose
      View All 8 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile